FHLC
Fidelity MSCI Health Care Index ETF · Financial Services · Asset Management - Global
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +18.0% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 54 | -1 | 10.10M | $780.52M | +6 | −7 |
| Q1 2026 | 56 | +4 | 9.57M | $672.90M | +7 | −3 |
| Q4 2025 | 52 | 0 | 8.99M | $652.96M | +1 | −1 |
| Q3 2025 | 8 | -1 | 778.54K | $52.06M | +1 | −2 |
| Q2 2025 | 6 | +1 | 372.42K | $23.82M | +1 | — |
| Q1 2025 | 4 | -1 | 51.66K | $3.53M | — | −1 |
| Q4 2024 | 5 | 0 | 172.32K | $11.26M | +2 | −2 |
| Q3 2024 | 5 | 0 | 146.09K | $10.64M | +1 | −1 |
| Q2 2024 | 5 | — | 69.74K | $4.79M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Two Sigma Investments ✦ | 119.70K | +32.7% | $7.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 19.17K | -9.2% | $1.25M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 13.19K | New | $861,705 | 0.0% | New | 1 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 10.39K | New | $679,183 | 0.0% | New | 1 | SEC ↗ |
| 5 | Fisher Asset Management ✦ | 9.87K | -3.5% | $645,297 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Citadel Advisors | $861,705 | 0.0% |
| D. E. Shaw & Co. | $679,183 | 0.0% |
Exited
| Marshall Wace | $906,943 | was 0.0% |
| Renaissance Technologies | $880,880 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 360 holders, 17.30M shares, $1.20B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.